PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update

NEXT STORY
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
PREV STORY
electroCore Announces First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance

BOSTON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP) today responded to ...

author_avatar
NASDAQ Market News

OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting

CG-806 Pan-FLT3/Pan-BTK Inhibitor Exhibits Favorable Safety Profile and Unexpected Potency on Primary Cells from ...

author_avatar
NASDAQ Market News

Orionin Tutkimussäätiö jakoi vuodelle 2019 apurahoina yhteensä yli miljoona euroa

Orionin Tutkimussäätiö sr         LEHDISTÖTIEDOTE     1.11.2018 KLO 9.30 Orionin Tutkimussäätiö jakoi vuodelle 2019 apurahoina yhteensä yli ...

author_avatar
NASDAQ Market News